Markets

Sunshine Biopharma Says CEO Steve Slilaty, Holder Of About 97% Of Voting Power, Approved Reverse Stock Split Of Up To 1-For-20 By Written Consent

Sep 16, 2026 · 04:17 PM ET· updated 2h ago

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826007193/sunshine_8k.htmhttps://www.sec.gov/Archives/edgar/data/1402328/000168316826007195/sunshine_pre14c.htm

Why It Matters

The company's main owner approved combining shares to make the stock price higher. When a company does this, watch whether it helps them stay listed on their exchange.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SBFM1.03

-0.01 (-0.49%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.